Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:The efficacy, safety and tolerability of canakinumab in the treatment of familial Mediterranean fever : a systematic review of the literature
Authors:ID Kačar, Mark, Klinika Golnik (Author)
ID Savic, Sinisa (Author)
ID van der Hilst, Jeroen CH (Author)
Files:.pdf PDF - Presentation file, download (463,72 KB)
MD5: D1827B5AB0D1319B2A600CD477DADF9E
 
URL URL - Source URL, visit https://www.dovepress.com/getfile.php?fileID=56642
 
Language:English
Typology:1.02 - Review Article
Organization:Logo UKPBAG - University Clinic of Respiratory and Allergic Diseases Golnik
Abstract:Familial Mediterranean Fever (FMF) is the most prevalent genetic autoinflammatory disorder. In most patients, treatment with colchicine can prevent attacks of fever and inflammation. However, 5%-10% of patients are resistant to colchicine treatment, while a similar percentage cannot tolerate colchicine in doses needed to prevent attacks. For these patients, Canakinumab, a full human antibody against IL-1[beta], has been approved recently by the FDA and EMA. In this article, we present a systematic review of the long-term efficacy, safety, and tolerability of Canakinumab in FMF patients who cannot tolerate colchicine or who are resistant to colchicine treatment.
Keywords:familial Mediterranean fever -- therapy -- review, monoclonal antibodies, canakinumab, anti-IL1 therapy
Publication status:Published
Publication version:Version of Record
Place of publishing:Nova Zelandija
Publisher:Dove Press
Year of publishing:2020
Number of pages:str. 141-149
Numbering:Vol. 13
PID:20.500.12556/DiRROS-13873 New window
UDC:577.2
ISSN on article:1178-7031
DOI:10.2147/JIR.S206204 New window
COBISS.SI-ID:58075139 New window
Copyright:© 2020 Kacar et al.
Note:Nasl. z nasl. zaslona; Opis vira z dne 1. 4. 2021;
Publication date in DiRROS:08.04.2021
Views:1295
Downloads:759
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Journal of inflammation research
Shortened title:J. inflamm. res.
Publisher:Dove Medical Press
ISSN:1178-7031
COBISS.SI-ID:523217433 New window

Licences

License:CC BY-NC 3.0, Creative Commons Attribution-NonCommercial 3.0 Unported
Link:http://creativecommons.org/licenses/by-nc/3.0/
Description:You are free to reproduce and redistribute the material in any medium or format. You are free to remix, transform, and build upon the material. You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Licensing start date:20.02.2020

Secondary language

Language:Undetermined
Keywords:družinska mediteranska vročica -- terapija -- pregled literature, monoklonska protitelesa, canakinumab, anti-IL1 terapija


Back